GenomeNet

Database: UniProt
Entry: O35305
LinkDB: O35305
Original site: O35305 
ID   TNR11_MOUSE             Reviewed;         625 AA.
AC   O35305; Q8VCT7;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   04-NOV-2026, entry version 179.
DE   RecName: Full=Tumor necrosis factor receptor superfamily member 11A;
DE   AltName: Full=Osteoclast differentiation factor receptor;
DE            Short=ODFR;
DE   AltName: Full=Receptor activator of NF-KB;
DE   AltName: CD_antigen=CD265;
DE   Flags: Precursor;
GN   Name=Tnfrsf11a; Synonyms=Rank;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Fetal liver;
RX   PubMed=9367155; DOI=10.1038/36593;
RA   Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C.,
RA   Tometsko M.E., Roux E.R., Teepe M.C., DuBose R.F., Cosman D., Galibert L.;
RT   "A homologue of the TNF receptor and its ligand enhance T-cell growth and
RT   dendritic-cell function.";
RL   Nature 390:175-179(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION.
RX   PubMed=9878548; DOI=10.1006/bbrc.1998.9788;
RA   Nakagawa N., Kinosaki M., Yamaguchi K., Shima N., Yasuda H., Yano K.,
RA   Morinaga T., Higashio K.;
RT   "RANK is the essential signaling receptor for osteoclast differentiation
RT   factor in osteoclastogenesis.";
RL   Biochem. Biophys. Res. Commun. 253:395-400(1998).
RN   [4]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH EEIG1; PLCY2; GAB2; TEC AND BTK,
RP   INTERACTION WITH EEIG1, AND SUBCELLULAR LOCATION.
RX   PubMed=23478294; DOI=10.1038/cr.2013.33;
RA   Choi H.K., Kang H.R., Jung E., Kim T.E., Lin J.J., Lee S.Y.;
RT   "Early estrogen-induced gene 1, a novel RANK signaling component, is
RT   essential for osteoclastogenesis.";
RL   Cell Res. 23:524-536(2013).
RN   [5]
RP   INTERACTION WITH STAC2, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   532-GLY--ILE-534; 535-ILE--VAL-537; 538-TYR--SER-540 AND 541-GLN--SER-543.
RX   PubMed=29348675; DOI=10.1038/s41418-017-0048-5;
RA   Jeong E., Choi H.K., Park J.H., Lee S.Y.;
RT   "STAC2 negatively regulates osteoclast formation by targeting the RANK
RT   signaling complex.";
RL   Cell Death Differ. 25:1364-1374(2018).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY ALONE AND IN COMPLEX WITH TNFSF11, DISULFIDE BONDS,
RP   FUNCTION, SODIUM-BINDING SITE, AND SUBUNIT.
RX   PubMed=20483727; DOI=10.4049/jimmunol.0904033;
RA   Liu C., Walter T.S., Huang P., Zhang S., Zhu X., Wu Y., Wedderburn L.R.,
RA   Tang P., Owens R.J., Stuart D.I., Ren J., Gao B.;
RT   "Structural and functional insights of RANKL-RANK interaction and
RT   signaling.";
RL   J. Immunol. 184:6910-6919(2010).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY IN COMPLEX WITH TNFSF11/RANKL, DISULFIDE BONDS, AND
RP   GLYCOSYLATION AT ASN-106.
RX   PubMed=23039992; DOI=10.1016/j.str.2012.08.030;
RA   Nelson C.A., Warren J.T., Wang M.W., Teitelbaum S.L., Fremont D.H.;
RT   "RANKL employs distinct binding modes to engage RANK and the
RT   osteoprotegerin decoy receptor.";
RL   Structure 20:1971-1982(2012).
CC   -!- FUNCTION: Receptor for TNFSF11/RANKL/TRANCE/OPGL; essential for RANKL-
CC       mediated osteoclastogenesis (PubMed:20483727, PubMed:23478294,
CC       PubMed:9878548). Its interaction with EEIG1 promotes osteoclastogenesis
CC       via facilitating the transcription of NFATC1 and activation of PLCG2
CC       (PubMed:23478294). Involved in the regulation of interactions between
CC       T-cells and dendritic cells (PubMed:9367155).
CC       {ECO:0000269|PubMed:20483727, ECO:0000269|PubMed:23478294,
CC       ECO:0000269|PubMed:9367155, ECO:0000269|PubMed:9878548}.
CC   -!- SUBUNIT: Binds to the clefts between the subunits of the TNFSF11 ligand
CC       trimer to form a heterohexamer (PubMed:20483727, PubMed:23039992). Part
CC       of a complex composed of EEIG1, TNFRSF11A/RANK, PLCG2, GAB2, TEC and
CC       BTK; complex formation increases in the presence of TNFSF11/RANKL
CC       (PubMed:23478294, PubMed:29348675). Interacts with TRAF1, TRAF2, TRAF3,
CC       TRAF5 and TRAF6 (By similarity). Interacts (via cytoplasmic domain)
CC       with GAB2 (By similarity). Interacts (via cytoplasmic domain); with
CC       EEIG1 (via N-terminus); when in the presence of TNFSF11/RANKL
CC       (PubMed:23478294). After TNFSF11 stimulation, interacts (via IVVY
CC       motif) with STAC2; this interaction affects TNFRSF11A interaction with
CC       PLCG2 and GAB2 (PubMed:29348675). {ECO:0000250|UniProtKB:Q9Y6Q6,
CC       ECO:0000269|PubMed:20483727, ECO:0000269|PubMed:23039992,
CC       ECO:0000269|PubMed:23478294, ECO:0000269|PubMed:29348675}.
CC   -!- INTERACTION:
CC       O35305; Q9Z1R2: Bag6; NbExp=4; IntAct=EBI-647362, EBI-644645;
CC       O35305; O35235-1: Tnfsf11; NbExp=6; IntAct=EBI-647362, EBI-15890886;
CC       O35305; P39429: Traf2; NbExp=2; IntAct=EBI-647362, EBI-520016;
CC       O35305; Q60803: Traf3; NbExp=3; IntAct=EBI-647362, EBI-520135;
CC       O35305; P70196: Traf6; NbExp=2; IntAct=EBI-647362, EBI-448028;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9Y6Q6};
CC       Single-pass type I membrane protein {ECO:0000255}. Membrane raft
CC       {ECO:0000269|PubMed:23478294, ECO:0000269|PubMed:29348675}.
CC       Note=Following TNFSF11/RANKL stimulation, recruited to lipid rafts
CC       along with STAC2. {ECO:0000269|PubMed:29348675}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous expression with high levels in
CC       trabecular bone, thymus, small intestine, lung, brain and kidney.
CC       Weakly expressed in spleen and bone marrow.
CC   -!- DOMAIN: The IVVY motif is required for efficient interaction with
CC       STAC2. {ECO:0000269|PubMed:29348675}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF019046; AAB86810.1; -; mRNA.
DR   EMBL; BC019185; AAH19185.1; -; mRNA.
DR   CCDS; CCDS15207.1; -.
DR   RefSeq; NP_033425.3; NM_009399.5.
DR   PDB; 3ME2; X-ray; 2.80 A; R=26-210.
DR   PDB; 3ME4; X-ray; 2.01 A; A/B=26-210.
DR   PDB; 3QBQ; X-ray; 2.50 A; B/D=32-201.
DR   PDB; 4GIQ; X-ray; 2.70 A; R=31-198.
DR   PDB; 5BNQ; X-ray; 2.80 A; R=26-210.
DR   AlphaFoldDB; O35305; -.
DR   SMR; O35305; -.
DR   BioGRID; 204246; 5.
DR   CORUM; O35305; -.
DR   DIP; DIP-48710N; -.
DR   ELM; O35305; -.
DR   FunCoup; O35305; 548.
DR   IntAct; O35305; 11.
DR   STRING; 10090.ENSMUSP00000027559; -.
DR   GlyCosmos; O35305; 2 sites, 1 glycan.
DR   GlyGen; O35305; 2 sites, 1 N-linked glycan (1 site).
DR   iPTMnet; O35305; -.
DR   PhosphoSitePlus; O35305; -.
DR   PaxDb; 10090-ENSMUSP00000027559; -.
DR   PeptideAtlas; O35305; -.
DR   ProteomicsDB; 260632; -.
DR   Antibodypedia; 4165; 918 antibodies from 48 providers.
DR   DNASU; 21934; -.
DR   Ensembl; ENSMPUT00000016649; ENSMPUP00000016404; ENSMPUG00000016507.
DR   Ensembl; ENSMUST00000027559.9; ENSMUSP00000027559.7; ENSMUSG00000026321.9.
DR   GeneID; 21934; -.
DR   KEGG; mmu:21934; -.
DR   UCSC; uc007cgp.1; mouse.
DR   AGR; MGI:1314891; -.
DR   CTD; 8792; -.
DR   MGI; MGI:1314891; Tnfrsf11a.
DR   VEuPathDB; HostDB:ENSMUSG00000026321; -.
DR   eggNOG; ENOG502RWJI; Eukaryota.
DR   GeneTree; ENSGT00940000161211; -.
DR   HOGENOM; CLU_026571_0_0_1; -.
DR   InParanoid; O35305; -.
DR   OMA; AAMLCLW; -.
DR   OrthoDB; 9889060at2759; -.
DR   PhylomeDB; O35305; -.
DR   Reactome; R-MMU-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-MMU-5676594; TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway.
DR   BioGRID-ORCS; 21934; 2 hits in 76 CRISPR screens.
DR   EvolutionaryTrace; O35305; -.
DR   PRO; PR:O35305; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; O35305; protein.
DR   Bgee; ENSMUSG00000026321; Expressed in left colon and 83 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:GO_Central.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0019955; F:cytokine binding; ISO:GO_Central.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; ISO:GO_Central.
DR   GO; GO:0005031; F:tumor necrosis factor receptor activity; IMP:BHF-UCL.
DR   GO; GO:0002250; P:adaptive immune response; ISO:GO_Central.
DR   GO; GO:0034224; P:cellular response to zinc ion starvation; IEA:Ensembl.
DR   GO; GO:0060086; P:circadian temperature homeostasis; IMP:BHF-UCL.
DR   GO; GO:0048535; P:lymph node development; IMP:MGI.
DR   GO; GO:0060749; P:mammary gland alveolus development; IMP:MGI.
DR   GO; GO:0072674; P:multinuclear osteoclast differentiation; IMP:MGI.
DR   GO; GO:0001503; P:ossification; IMP:MGI.
DR   GO; GO:0030316; P:osteoclast differentiation; ISO:GO_Central.
DR   GO; GO:0045780; P:positive regulation of bone resorption; IMP:MGI.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISO:GO_Central.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:GO_Central.
DR   GO; GO:0071812; P:positive regulation of fever generation by positive regulation of prostaglandin secretion; IMP:BHF-UCL.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:GO_Central.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISO:GO_Central.
DR   GO; GO:0045672; P:positive regulation of osteoclast differentiation; IMP:UniProtKB.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0070555; P:response to interleukin-1; IMP:BHF-UCL.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IMP:BHF-UCL.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IMP:BHF-UCL.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IMP:BHF-UCL.
DR   CDD; cd13411; TNFRSF11A; 1.
DR   FunFam; 2.10.50.10:FF:000015; TNF receptor superfamily member 11a; 1.
DR   FunFam; 2.10.50.10:FF:000019; Tumor necrosis factor receptor superfamily member 11A; 1.
DR   Gene3D; 2.10.50.10; Tumor Necrosis Factor Receptor, subunit A, domain 2; 2.
DR   InterPro; IPR041648; RANK_CRD_2.
DR   InterPro; IPR001368; TNFR/NGFR_Cys_rich_reg.
DR   InterPro; IPR022323; TNFR_11.
DR   InterPro; IPR022361; TNFR_11A.
DR   InterPro; IPR053075; TNFRSF11A.
DR   InterPro; IPR034040; TNFRSF11A_N.
DR   PANTHER; PTHR47134; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 11A; 1.
DR   PANTHER; PTHR47134:SF1; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 11A; 1.
DR   Pfam; PF18278; RANK_CRD_2; 1.
DR   Pfam; PF00020; TNFR_c6; 1.
DR   PRINTS; PR01961; TNFACTORR11.
DR   PRINTS; PR01974; TNFACTORR11A.
DR   SMART; SM00208; TNFR; 4.
DR   SUPFAM; SSF57586; TNF receptor-like; 2.
DR   PROSITE; PS00652; TNFR_NGFR_1; 1.
DR   PROSITE; PS50050; TNFR_NGFR_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; Glycoprotein; Membrane;
KW   Metal-binding; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Signal; Sodium; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000255"
FT   CHAIN           31..625
FT                   /note="Tumor necrosis factor receptor superfamily member
FT                   11A"
FT                   /id="PRO_0000034586"
FT   TOPO_DOM        31..214
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        215..234
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        235..625
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          35..69
FT                   /note="TNFR-Cys 1"
FT   REPEAT          72..113
FT                   /note="TNFR-Cys 2"
FT   REPEAT          115..152
FT                   /note="TNFR-Cys 3"
FT   REPEAT          155..195
FT                   /note="TNFR-Cys 4"
FT   REGION          331..356
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          388..413
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          479..524
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          532..537
FT                   /note="Required for interaction with EEIG1 and osteoclast
FT                   differentiation"
FT                   /evidence="ECO:0000269|PubMed:23478294"
FT   REGION          542..625
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           535..538
FT                   /note="IVVY motif"
FT   COMPBIAS        499..511
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        512..524
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        543..558
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        561..571
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        603..625
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         134
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT   BINDING         135
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT   BINDING         138
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT   BINDING         161
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT   BINDING         163
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT   MOD_RES         571
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q6"
FT   CARBOHYD        106
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:23039992"
FT   CARBOHYD        175
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        35..47
FT   DISULFID        48..61
FT   DISULFID        51..69
FT   DISULFID        72..87
FT   DISULFID        93..113
FT   DISULFID        115..128
FT   DISULFID        125..127
FT   DISULFID        134..152
FT   DISULFID        155..170
FT   DISULFID        176..195
FT   MUTAGEN         532..534
FT                   /note="GDI->AAA: Some decrease in interaction with STAC2."
FT                   /evidence="ECO:0000269|PubMed:29348675"
FT   MUTAGEN         535..537
FT                   /note="IVV->AAA: Almost complete loss of interaction with
FT                   STAC2."
FT                   /evidence="ECO:0000269|PubMed:29348675"
FT   MUTAGEN         538..540
FT                   /note="YVS->AAA: Almost complete loss of interaction with
FT                   STAC2."
FT                   /evidence="ECO:0000269|PubMed:29348675"
FT   MUTAGEN         541..543
FT                   /note="QTS->AAA: No effect on interaction with STAC2."
FT                   /evidence="ECO:0000269|PubMed:29348675"
FT   CONFLICT        494
FT                   /note="R -> K (in Ref. 2; AAH19185)"
FT                   /evidence="ECO:0000305"
FT   TURN            37..39
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          40..43
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          46..49
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          55..59
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          63..65
FT                   /evidence="ECO:0007829|PDB:3QBQ"
FT   STRAND          68..71
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          80..82
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   HELIX           90..93
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   HELIX           95..97
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          99..103
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          107..109
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          112..115
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          119..122
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   TURN            123..126
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          127..130
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          138..140
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          142..145
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          146..148
FT                   /evidence="ECO:0007829|PDB:4GIQ"
FT   STRAND          152..154
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          165..167
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   HELIX           176..179
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          183..185
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          189..191
FT                   /evidence="ECO:0007829|PDB:3ME4"
FT   STRAND          194..196
FT                   /evidence="ECO:0007829|PDB:3QBQ"
SQ   SEQUENCE   625 AA;  66621 MW;  F8C1872E99511D8E CRC64;
     MAPRARRRRQ LPAPLLALCV LLVPLQVTLQ VTPPCTQERH YEHLGRCCSR CEPGKYLSSK
     CTPTSDSVCL PCGPDEYLDT WNEEDKCLLH KVCDAGKALV AVDPGNHTAP RRCACTAGYH
     WNSDCECCRR NTECAPGFGA QHPLQLNKDT VCTPCLLGFF SDVFSSTDKC KPWTNCTLLG
     KLEAHQGTTE SDVVCSSSMT LRRPPKEAQA YLPSLIVLLL FISVVVVAAI IFGVYYRKGG
     KALTANLWNW VNDACSSLSG NKESSGDRCA GSHSATSSQQ EVCEGILLMT REEKMVPEDG
     AGVCGPVCAA GGPWAEVRDS RTFTLVSEVE TQGDLSRKIP TEDEYTDRPS QPSTGSLLLI
     QQGSKSIPPF QEPLEVGEND SLSQCFTGTE STVDSEGCDF TEPPSRTDSM PVSPEKHLTK
     EIEGDSCLPW VVSSNSTDGY TGSGNTPGED HEPFPGSLKC GPLPQCAYSM GFPSEAAASM
     AEAGVRPQDR ADERGASGSG SSPSDQPPAS GNVTGNSNST FISSGQVMNF KGDIIVVYVS
     QTSQEGPGSA EPESEPVGRP VQEETLAHRD SFAGTAPRFP DVCATGAGLQ EQGAPRQKDG
     TSRPVQEQGG AQTSLHTQGS GQCAE
//
DBGET integrated database retrieval system